Chemokines and graft-versus-host disease - Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation - page 416

[36] Eriguchi Y, Takashima S, Oka H, Shimoji S, Nakamura K, Uryu H, et al. Graft-versus-
host disease disrupts intestinal microbial ecology by inhibiting Paneth cell production
of α-defensins. Blood 2012;120:223-31.
[37] Wysocki CA, Panoskaltsis-Mortari A, Blazar BR, Serody JS. Leukocyte migration and
graft-versus-host disease. Blood 2005;105:4191-9.
[38] Loetscher M, Gerber B, Loetscher P, Jones SA, Piali L, Clark-Lewis I, et al. Chemokine
receptor specific for IP10 and Mig: structure, function, and expression in activated
T-lymphocytes. J Exp Med 1996;184:963-9.
[39] Qin S, Rottman JB, Myers P, Kassam N, Weinblatt M, Loetscher M, et al. The chemokine
receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflamma-
tory reactions. J Clin Invest 1998;101:746-54.
[40] Kunkel EJ, Boisvert J, Murphy K, Vierra MA, Genovese MC, Wardlaw AJ, et al. Expres-
sion of the chemokine receptors CCR4, CCR5, and CXCR3 by human tissue-infiltrating
lymphocytes. Am J Pathol 2002;160:347-55.
[41] Ebert LM, McColl SR. Coregulation of CXC chemokine receptor and CD4 expression on
T lymphocytes during allogeneic activation. J Immunol 2001;166:4870-8.
[42] von Andrian UH, Mackay CR. T-cell function and migration: two sides of the same coin.
N Engl J Med 2000;343:1020-34.
[43] Murdoch C, Finn A. Chemokine receptors and their role in inflammation and infectious
diseases. Blood 2000;95:3032-43.
[44] Murai M, Yoneyama H, Harada A, Yi Z, Vestergaard C, Guo B, et al. Active participation
of CCR5(+)CD8(+) T lymphocytes in the pathogenesis of liver injury in graft-versus-host
disease. J Clin Invest 1999;104:49-57.
[45] Duffner U, Lu B, Hildebrandt GC, Teshima T, Williams DL, Reddy P, et al. Role of
CXCR3-induced donor T-cell migration in acute GVHD. Exp Hematol 2003;31:897-902.
[46] Panoskaltsis-Mortari A, Strieter RM, Hermanson JR, Fegeding KV, Murphy WJ, Farrell
CL, et al. Induction of monocyte- and T-cell-attracting chemokines in the lung during
the generation of idiopathic pneumonia syndrome following allogeneic murine bone
marrow transplantation. Blood 2000;96:834-9.
[47] Hildebrandt GC, Corrion LA, Olkiewicz KM, Lu B, Lowler K, Duffner UA, et al. Block-
ade of CXCR3 receptor:ligand interactions reduces leukocyte recruitment to the
lung and the severity of experimental idiopathic pneumonia syndrome. J Immunol
2004;173:2050-9.
[48] Agostini C, Calabrese F, Rea F, Facco M, Tosoni A, Loy M, et al. Cxcr3 and its ligand
CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate
chemotaxis of T cells at sites of rejection. Am J Pathol 2001;158:1703-11.
[49] Deurloo D, MN C, Olkiewicz K, Silva I, Choi S, Liu C, et al. A small molecular weight
antagonist of CXCR-3 reduces the severity of experimental idiopathic pneumonia syn-
drome and improves survival following allogeneic stem cell transplantation. Biol Blood
Marrow Transplant 2007;13:105.
[50] Piper KP, Horlock C, Curnow SJ, Arrazi J, Nicholls S, Mahendra P, et al. CXCL10-
CXCR3 interactions play an important role in the pathogenesis of acute graft-ver-
sus-host disease in the skin following allogeneic stem-cell transplantation. Blood
2007;110:3827-32.
[51] Horuk R. Survey: chemokine receptors. Cytokine Growth Factor Rev 2001;12:313-35.
[52] Song A, Nikolcheva T, Krensky AM. Transcriptional regulation of RANTES expression in
T lymphocytes. Immunol Rev 2000;177:236-45.
[53] Mack M, Cihak J, Simonis C, Luckow B, Proudfoot AE, Plachy J, et al. Expression and
characterization of the chemokine receptors CCR2 and CCR5 in mice. J Immunol
2001;166:4697-704.
[54] Odum N, Bregenholt S, Eriksen KW, Skov S, Ryder LP, Bendtzen K, et al. The CC-
chemokine receptor 5 (CCR5) is a marker of, but not essential for the development of
human Th1 cells. Tissue Antigens 1999;54:572-7.
[55] Fischereder M, Luckow B, Hocher B, Wuthrich RP, Rothenpieler U, Schneeberger H,
et al. CC chemokine receptor 5 and renal-transplant survival. Lancet 2001;357:
1758-61.
[56] Serody JS, Burkett SE, Panoskaltsis-Mortari A, Ng-Cashin J, McMahon E, Matsushima
GK, et al. T-lymphocyte production of macrophage inflammatory protein-1alpha is
critical to the recruitment of CD8(+) T cells to the liver, lung, and spleen during graft-
versus-host disease. Blood 2000;96:2973-80.
[57] Panoskaltsis-Mortari A, Hermanson JR, Taras E, Wangensteen OD, Serody JS, Blazar BR.
Acceleration of idiopathic pneumonia syndrome (IPS) in the absence of donor MIP-
1{alpha} (CCL3) post-allogeneic BMT in mice. Blood 2003;2:2.
[58] Murai M, Yoneyama H, Ezaki T, Suematsu M, Terashima Y, Harada A, et al. Peyer's patch
is the essential site in initiating murine acute and lethal graft-versus-host reaction. Nat
Immunol 2003;4:154-60.

421